Evidence map›Paper›PMID 40210814›Full record

ArticleBiological trace element research2025

Ferulic Acid Ameliorates Chromium-Induced Nephrotoxicity: Modulation of PERK/eIF2α/ATF4/CHOP, Nrf2, and Inflammatory Signaling.

Samyah T Alanazi, Samir A Salama, Musaad M Althobaiti, Abdullah M Almalki, Afnan Bakhsh, Arafa Musa, Alaa A Mohammed

Abstract read
PubMed Publisher
In one paragraph

Article in Biological trace element research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Samyah T AlanaziDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, 11433, Riyadh, Saudi Arabia.
Samir A SalamaDivision of Biochemistry, Department of Pharmacology and Toxicology, College of Pharmacy, Taif University, P.O. Box 11099, 21944, Taif, Saudi Arabia. s.salama@tu.edu.sa.ORCID http://orcid.org/0000-0002-5210-1781
Musaad M AlthobaitiDepartment of Pharmacology and Toxicology, College of Pharmacy, Taif University, P.O. Box 11099, 21944, Taif, Saudi Arabia.
Abdullah M AlmalkiCollege of Pharmacy, Taif University, P.O. Box 11099, 21944, Taif, Saudi Arabia.
Afnan BakhshDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, 11433, Riyadh, Saudi Arabia.
Arafa MusaDepartment of Pharmacognosy, College of Pharmacy, Jouf University, 72341, Sakaka, Aljouf, Saudi Arabia.
Alaa A MohammedMedical Biochemistry Division, Pathology Department, College of Medicine, Jouf University, Aljouf, 72388, Kingdom of Saudi Arabia.

Funding

Taif University TU-DSPP-2024-142
6 · The paper itself

Abstract

Hexavalent chromium (HVC) is a highly toxic heavy metal that induces organ damage especially to the kidney. It induces tubular damage and glomerular dysfunction basically through triggering inflammation, redox imbalance, and apoptotic cell death. The current study aimed at investigating the possible protective ability of ferulic acid (FA) against HVC-induced nephrotoxicity employing male Wistar rats as an experimental model. The results revealed the ability of FA to suppress the HVC-evoked renal tissue injury and to improve the renal function, as evidenced by enhanced histopathological picture, reduced levels of the tubular injury biomarker KIM- 1, and the glomerular dysfunction biomarkers serum cystatin C and urea, along with boosted glomerular filtration rate. At the molecular level, FA suppressed HVC-induced inflammation, as indicated by decreased nuclear NF-κB p65 protein abundance and phosphorylation, and reduced cyclooxygenase- 2, IL- 1β, and TNF-α levels. FA significantly alleviated the HVC-induced redox imbalance as demonstrated by reduced lipids and DNA oxidation, upregulation of Nrf2 signaling, improved activity of the antioxidant enzymes thioredoxin reductase, catalase, and glutathione peroxidase, along with significant elevation of the reduced glutathione level. FA inhibited apoptosis in the HVC-intoxicated rats as evidenced by reduced activity of the apoptotic marker caspase- 3 and modulation of BAX and Bcl2 proteins. Interestingly, FA suppressed the unfolded protein response signaling molecules including PERK, eIF2α, ATF4, and CHOP, which play essential roles in induction of apoptosis and inflammation. Together, these results underscore the nephroprotective impact of FA against HVC-evoked nephrotoxicity and highlight PERK, eIF2α, ATF4, CHOP, Nrf2, and NF-κB as potential molecular targets.

Indexed as

ChromiumCoumaric AcidsInflammationKidneyKidney DiseasesSignal TransductionActivating Transcription Factor 4AnimalseIF-2 KinaseEukaryotic Initiation Factor-2MaleNF-E2-Related Factor 2RatsRats, WistarTranscription Factor CHOPActivating Transcription Factor 4Atf4 protein, ratChromiumchromium hexavalent ionCoumaric AcidsDdit3 protein, rateIF-2 KinaseEukaryotic Initiation Factor-2ferulic acidNfe2l2 protein, ratNF-E2-Related Factor 2Transcription Factor CHOPCHOPFerulic acidHexavalent chromiumNephrotoxicityNrf2

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.